tiprankstipranks
Trending News
More News >
Apellis price target lowered to $41 from $49 at Citi
PremiumThe FlyApellis price target lowered to $41 from $49 at Citi
15d ago
Apellis price target lowered to $20 from $30 at Mizuho
Premium
The Fly
Apellis price target lowered to $20 from $30 at Mizuho
23d ago
Buy Recommendation for Apellis Pharmaceuticals Driven by Syfovre’s Market Potential and Strategic Expansion
Premium
Ratings
Buy Recommendation for Apellis Pharmaceuticals Driven by Syfovre’s Market Potential and Strategic Expansion
26d ago
Apellis price target lowered to $47 from $55 at Baird
PremiumThe FlyApellis price target lowered to $47 from $55 at Baird
29d ago
Apellis price target lowered to $26 from $30 at Wells Fargo
Premium
The Fly
Apellis price target lowered to $26 from $30 at Wells Fargo
29d ago
Optimistic Growth Potential for Apellis Pharmaceuticals Despite Temporary Setbacks
Premium
Ratings
Optimistic Growth Potential for Apellis Pharmaceuticals Despite Temporary Setbacks
29d ago
Apellis Pharmaceuticals: Buy Rating Reaffirmed Amid Growth Potential and Market Leadership in GA
PremiumRatingsApellis Pharmaceuticals: Buy Rating Reaffirmed Amid Growth Potential and Market Leadership in GA
30d ago
Apellis Pharmaceuticals: Long-term Growth Potential and Market Recovery Underpin Buy Rating
Premium
Ratings
Apellis Pharmaceuticals: Long-term Growth Potential and Market Recovery Underpin Buy Rating
1M ago
Apellis reports Q1 EPS (74c), consensus (35c)
Premium
The Fly
Apellis reports Q1 EPS (74c), consensus (35c)
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100